Company Overview of Sinapis Pharma, Inc.
Sinapis Pharma, Inc, a drug development company, engages in the discovery and development of methamphetamine, an intravenous neuroprotective agent for the treatment of acute stroke and brain injury. The company was incorporated in 2009 and is based in Jacksonville, Florida.
3610 Holly Grove Avenue
Jacksonville, FL 32217
Founded in 2009
Key Executives for Sinapis Pharma, Inc.
Similar Private Companies By Industry
|MaxThera, Inc.||United States|
|Vensun Pharmaceuticals, Inc.||United States|
|Surgical Technologies, Inc.||United States|
|AZTherapies, Inc.||United States|
|Sigma Global Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Madison, WI | AstellasPosted: Apr 11
- Deerfield, IL | Takeda Pharmaceuticals North AmericaPosted: Apr 15
- Chicago, IL | PwCPosted: Aug 20
- New York, NY | PwCPosted: Aug 20
Sponsored Financial Commentaries
To contact Sinapis Pharma, Inc., please visit www.sinapispharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.